Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6XPP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, for the supply of Xtandi 40 mg capsules (120-count units) to the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, valued at $4,311.35, represents performance through July 29, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply chain, enabling the Department of Defense to procure this oncology medication for military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The SPE2DB program contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group's consistent success in securing federal contracts without set-aside designations demonstrates its competitive positioning in pharmaceutical procurement markets and reinforces its role as a direct distributor of specialty medications to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DX25F6XPP?
SPE2DX25F6XPP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DX25F6XPP worth?
The government has obligated $4,311 on SPE2DX25F6XPP.
Is contract SPE2DX25F6XPP an order under another contract?
Yes. SPE2DX25F6XPP is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPP competed?
The extent of competition for SPE2DX25F6XPP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award